1. Home
  2. MIRA vs SBFM Comparison

MIRA vs SBFM Comparison

Compare MIRA & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • SBFM
  • Stock Information
  • Founded
  • MIRA 2020
  • SBFM 2006
  • Country
  • MIRA United States
  • SBFM Canada
  • Employees
  • MIRA N/A
  • SBFM N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • SBFM Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIRA Health Care
  • SBFM Health Care
  • Exchange
  • MIRA Nasdaq
  • SBFM Nasdaq
  • Market Cap
  • MIRA 10.2M
  • SBFM 6.3M
  • IPO Year
  • MIRA 2023
  • SBFM N/A
  • Fundamental
  • Price
  • MIRA $2.36
  • SBFM $0.30
  • Analyst Decision
  • MIRA
  • SBFM Strong Buy
  • Analyst Count
  • MIRA 0
  • SBFM 1
  • Target Price
  • MIRA N/A
  • SBFM $260.00
  • AVG Volume (30 Days)
  • MIRA 11.4M
  • SBFM 1.2M
  • Earning Date
  • MIRA 09-13-2024
  • SBFM 08-08-2024
  • Dividend Yield
  • MIRA N/A
  • SBFM N/A
  • EPS Growth
  • MIRA N/A
  • SBFM N/A
  • EPS
  • MIRA N/A
  • SBFM N/A
  • Revenue
  • MIRA N/A
  • SBFM $26,739,780.00
  • Revenue This Year
  • MIRA N/A
  • SBFM $87.97
  • Revenue Next Year
  • MIRA N/A
  • SBFM $125.23
  • P/E Ratio
  • MIRA N/A
  • SBFM N/A
  • Revenue Growth
  • MIRA N/A
  • SBFM 193.30
  • 52 Week Low
  • MIRA $0.51
  • SBFM $0.28
  • 52 Week High
  • MIRA $6.95
  • SBFM $64.50
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 59.37
  • SBFM 35.63
  • Support Level
  • MIRA $0.62
  • SBFM $0.29
  • Resistance Level
  • MIRA $5.01
  • SBFM $0.35
  • Average True Range (ATR)
  • MIRA 0.57
  • SBFM 0.03
  • MACD
  • MIRA 0.26
  • SBFM 0.03
  • Stochastic Oscillator
  • MIRA 41.07
  • SBFM 16.13

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.

Share on Social Networks: